Skip to content

Growth and Tolerance Trial on Infant Formula With HMO

Growth and Tolerance Trial in Healthy Infants on Infant Formula Supplemented With a Human Milk Oligosaccharide

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04066413
Acronym
Stardust
Enrollment
265
Registered
2019-08-26
Start date
2019-09-23
Completion date
2023-01-26
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Growth

Keywords

infant formula, human milk oligosaccharide, HMO, growth

Brief summary

The aim of the study is to compare growth of healthy infants fed an infant formula supplemented with a human milk oligosaccharide to that of infants on standard formula.

Interventions

Standard infant formula

OTHERInfant formula supplemented with HMO

Infant formula supplemented with HMO

Sponsors

FrieslandCampina
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
Yes

Inclusion criteria

* Gestational age ≥ 37 weeks * Birth weight ≥ 2500 grams * No recognized diseases (such as cardiac, pulmonary, gastrointestinal, renal or genetic diseases) * Boys and girls * Recruited \< 1 month/age * Being available for follow up until the age of 4 months * Exclusive formula feeding or exclusive breast feeding at time of recruitment

Exclusion criteria

* Gestational age \<37 weeks * Birth weight \<2500 grams * Severe acquired or congenital diseases, mental or physical disorders * Illness at screening/ inclusion * Incapability of parents/caregivers to comply with the study protocol * Received antibiotics within the first month of life * Not tolerating standard cow's milk based infant formula * Participation in another clinical trial * Maternal illicit drug use during pregnancy or post-partum period * Parent/caregiver does not have a cell phone to use for filling out questionnaires

Design outcomes

Primary

MeasureTime frameDescription
GrowthFrom enrollment until end of the 3 month-studyInfant growth measured as body weight gain per day

Secondary

MeasureTime frameDescription
Recumbent lengthMonthly, from enrollment until end of the 3 month-studyInfant length (cm and cm/day)
Head circumferenceMonthly, from enrollment until end of the 3 month-studyHead circumference (cm and cm/day)
WeightMonthly, from enrollment until end of the 3 month-studyInfant weight (kg)
Formula toleranceMonthly, from enrollment until end of the 3 month-studyParents are asked to keep a diary on formula intake 3 days prior to each monthly study visit
Gastro-intestinal comfortMonthly, from enrollment until end of the 3 month-studyParents are asked to keep a diary 3 days prior to each monthly study visit including questions on gastro-intestinal symptoms (e.g. cramps, constipation, vomiting) and crying behavior
Anthropometry z-scoresMonthly, from enrollment until end of the 3 month-studyWorld Health Organization (WHO) growth standard calculated z-scores for weight, length, weight-for-length and head circumference

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026